BIIB122 225 mg

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

BIIB122 225 mg
Treatment and conditionWhere it standsTrials
BIIB122 225 mg for parkinson diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1